NIH-funded research NIH-funded research

FSH hormone link to memory loss and bone fractures in older adults

Official title: Role of FSH in Coupling Dementia and Fracture in the AGES-Reykjavik Cohort of Older Adults

Funded at Icahn School of Medicine at Mount Sinai · NIH-11365795 · Data updated 2026-11-12

Researchers are looking at whether higher levels of the hormone FSH are connected to memory problems and weaker bones in older adults, especially postmenopausal women.

More Dementia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startFebruary 1, 2019
Project endApril 30, 2029
Funding year2026
Award (this year)$428,387
NIH project number5U19AG060917-08
Project IDNIH-11365795 on NIH RePORTER

Who could benefit from this research

Could help

The research is most relevant to older adults, particularly postmenopausal women, who have concerns about cognitive decline or low bone density.

Less likely to help

Younger adults or people without signs of memory problems or bone loss are unlikely to gain direct benefit from this project.

What this research studies

I would be part of a project that uses long-term health data from older adults in the AGES-Reykjavik group to compare blood FSH levels with memory tests, dementia diagnoses, and bone density or fractures. The team combines that human data with laboratory findings that suggest FSH can affect brain cells and bone. They will analyze blood samples, cognitive test results, imaging and bone measurements already collected in the cohort to see how these things move together over time. The goal is to understand whether a shared hormonal change could explain why dementia and fractures often occur together in aging.

Why it matters

Potential benefit: If the link is confirmed, the work could point to new ways to prevent or treat both memory decline and bone loss by targeting FSH-related pathways.

How similar studies have gone: Animal studies report that FSH can drive cognitive decline and prior analyses in this cohort have found correlations between high FSH, low bone density, and fractures, but clear proof in people is still limited.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Schafer, Anne Louise — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Schafer, Anne Louise

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.